Valuation : Vitrolife AB

Market Cap 12.55B 1.31B 1.13B 1.06B 967M 1.8B 124B 1.81B 4.86B 63.47B 4.92B 4.81B 202B P/E 2026 *
25.5x
P/E 2027 * 20.6x
Enterprise Value 13.1B 1.37B 1.18B 1.11B 1.01B 1.88B 130B 1.89B 5.07B 66.25B 5.13B 5.02B 211B EV / Sales 2026 *
3.79x
EV / Sales 2027 * 3.38x
Free-Float
54.39%
Yield 2026 *
1.19%
Yield 2027 * 1.36%
1 day-0.49%
1 week-2.80%
Current month-3.11%
1 month+3.26%
3 months-2.85%
6 months-0.16%
Current year-32.92%
1 week 91.1
Extreme 91.1
96.7
1 month 87
Extreme 87
98.1
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 01/08/2023
Director of Finance/CFO 55 10/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 19/04/2013
Chairman 70 01/08/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap. Importance
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%-2.80%-33.31%-31.42% 1.31B
-0.27%-2.09%+167.56%+377.40% 21.6B
-0.35%-5.03%-37.24%-22.02% 9.86B
+4.71%+9.37%+370.93%+38.51% 8.55B
-1.00%+0.16%-28.70% - 7.01B
-0.52%-0.44%+87.28%+51.27% 6.56B
-2.12%-1.68%-26.90%-19.34% 5.84B
+0.87%-2.78%-9.48%-20.01% 4.24B
-3.51%-2.89%+70.20%+84.91% 4.2B
-0.86%-2.60%-23.91%-29.78% 2.74B
Average -0.35%-0.80%+53.64%+47.72% 7.19B
Weighted average by Cap. -0.08%-0.72%+94.32%+133.09%

Financials

2026 *2027 *
Net sales 3.46B 361M 310M 292M 266M 497M 34.2B 500M 1.34B 17.48B 1.35B 1.33B 55.63B 3.71B 387M 333M 313M 286M 533M 36.67B 536M 1.43B 18.74B 1.45B 1.42B 59.65B
Net income 493M 51.39M 44.18M 41.57M 37.93M 70.79M 4.87B 71.16M 191M 2.49B 193M 189M 7.92B 609M 63.52M 54.61M 51.38M 46.89M 87.5M 6.02B 87.95M 236M 3.08B 239M 233M 9.79B
Net Debt 549M 57.29M 49.26M 46.34M 42.29M 78.92M 5.43B 79.32M 212M 2.78B 215M 210M 8.83B -26.74M -2.79M -2.4M -2.26M -2.06M -3.84M -264M -3.86M -10.34M -135M -10.48M -10.25M -430M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
09/09/26 SEK 91.90 -0.86% 9,483
08/09/26 SEK 92.70 -0.86% 94,641
07/09/26 SEK 93.50 -1.58% 80,617
04/09/26 SEK 95.00 -1.50% 70,182
03/09/26 SEK 96.45 +2.01% 268,907
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
92.70SEK
Average target price
129.60SEK
Spread / Average Target
+39.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!